CONDENSED CONSOLIDATED CASH FLOW STATEMENTS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jul. 01, 2012
Cash flows from operating activities:
Net income	$ 51,737	$ 66,665
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation and amortization	47,787	23,659
Share-based compensation	7,366	6,339
Pension funding less than pension expense	1,723	883
Provision for inventory obsolescence	963	3,056
Deferred income tax benefit	(897)	(10,368)
Income from equity method investment	(4,527)	(4,701)
Tax benefit related to share-based compensation	(5,362)	(3,909)
Changes in operating assets and liabilities, net of the effects of currency exchange rate changes and acquired businesses:
Receivables	(43,370)	(27,553)
Inventories	6,312	13,418
Accounts payable	5,500	(10,823)
Accrued liabilities	(1,854)	(23,754)
Accrued taxes	(85,769)	3,566
Other assets	232	(1,832)
Other liabilities	3,659	(4,084)
Net cash provided by (used for) operating activities	(16,500)	30,562
Cash flows from investing activities:
Capital expenditures	(20,266)	(21,753)
Cash used to acquire businesses, net of cash acquired	(9,979)	(587)
Proceeds from disposal of tangible assets	3,136	353
Proceeds from disposal of business	3,735
Net cash used for investing activities	(23,374)	(21,987)
Cash flows from financing activities:
Borrowings under credit arrangements	388,220
Payments under borrowing arrangements	(197,191)	(600)
Payments under share repurchase program	(62,500)	(50,000)
Debt issuance costs paid	(7,817)
Cash dividends paid	(2,310)	(4,712)
Proceeds (payments) from exercise of stock options, net of withholding tax payments	(1,186)	2,198
Proceeds from settlement of derivatives		2,733
Tax benefit related to share-based compensation	5,362	3,909
Net cash provided by (used for) financing activities	122,578	(46,472)
Effect of foreign currency exchange rate changes on cash and cash equivalents	(1,598)	(7,541)
Increase (decrease) in cash and cash equivalents	81,106	(45,438)
Cash and cash equivalents, beginning of period	395,095	382,716
Cash and cash equivalents, end of period	$ 476,201	$ 337,278